Brain Tumour Medication


Categories: Campaign Emails

The system for which drugs are made available on the NHS in Scotland is different from that of England.

The Scottish NHS seeks guidance from the Scottish Medicines Consortium (SMC) rather than NICE. Everolimus has not yet been submitted by the holder of the marketing authorisation for consideration for this use in Scotland.  The SMC are therefore unable to recommend its use at present.

I understand that the procedures that new drugs have to pass through can often seem complex and frustrating. But these processes exist to ensure that the NHS provides the best possible treatment to all patients.

Share this post:
Website issued by Martin Docherty-Hughes MP, Member of Parliament for West Dunbartonshire (SNP)

This website is funded by the Independent Parliamentary Standards Authority (IPSA) for the purpose of assisting Martin Docherty-Hughes MP in the performance of their Parliamentary duties. 
Formal feedback about website content should be sent to
The UK Parliament has no responsibility for the content of externally-linked sites

Titan Enterprise Centre, Suite 1-11, 1 Aurora Avenue, 1 Queens Quay, Clydebank G81 1BF

Contact form

0141 952 2988 Local office

Privacy / Cookies & IPs

Site build:

Newsletter sign-up

Leave this field blank